David L. Halladay

2.1k citations

25 papers · 1.7k indexed · h-index 19

Co-authors: Rebecca R. Miles Jude E. Onyia Xuhao Yang T. John Martin Rachelle J. Sells Galvin Kannan Thirunavukkarasu Yanfei Li S. Chandrasekhar
Topics: Bone health and treatments (14 papers)Bone Metabolism and Diseases (14 papers)Wnt/β-catenin signaling in development and cancer (4 papers)
Cited by: Orthopedics and Sports Medicine Oncology Nephrology
Journals: Journal of Biological Chemistry The Journal of Experimental Medicine Biochemical and Biophysical Research Communications
Partner nations: United States Australia

In The Last Decade

David L. Halladay

25 papers receiving 1.6k citations

Peers

Countries citing papers authored by David L. Halladay

Since Specialization

Citations

This map shows the geographic impact of David L. Halladay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Halladay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Halladay more than expected).

Fields of papers citing papers by David L. Halladay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Halladay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Halladay. The network helps show where David L. Halladay may publish in the future.

Co-authorship network of co-authors of David L. Halladay

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Halladay. A scholar is included among the top collaborators of David L. Halladay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Halladay. David L. Halladay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A proteomic analysis of adult rat bone reveals the presence of cartilage/chondrocyte markers 2007 ·Journal of Cellular Biochemistry ·(unknown),Jon P. Butler,Nalini H. Kulkarni,Michael D. Knierman,Richard E. Higgs,David L. Halladay,Jude E. Onyia,John E. Hale	32
2	Changes in Osteoblast, Chondrocyte, and Adipocyte Lineages Mediate the Bone Anabolic Actions of PTH and Small Molecule GSK‐3 Inhibitor 2007 ·Journal of Cellular Biochemistry ·Nalini H. Kulkarni,Tao Wei,(unknown),Ernst R. Dow,Trent R. Stewart,Jianyong Shou,(unknown),(unknown),Bruce D. Gitter,Richard E. Higgs,David L. Halladay,Thomas A. Engler,T. John Martin,Henry U. Bryant,Yanfei Li,Jude E. Onyia	54
3	High-Content Screening Assay for Activators of the Wnt/Fzd Pathway in Primary Human Cells 2005 ·Assay and Drug Development Technologies ·(unknown),Rachelle J. Sells Galvin,Charles A. Frolik,Laura V. Hale,David L. Halladay,(unknown),O. Joseph Trask,(unknown),Keith A. Houck	35
4	Effects of parathyroid hormone on Wnt signaling pathway in bone 2005 ·Journal of Cellular Biochemistry ·Nalini H. Kulkarni,David L. Halladay,Rebecca R. Miles,(unknown),Charles A. Frolik,Rachelle J. Sells Galvin,T. John Martin,Matthew T. Gillespie,J.E. Onyia	173
5	Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis by DNA microarray 2005 ·Journal of Cellular Biochemistry ·Jude E. Onyia,Leah M. Helvering,Lawrence M. Gelbert,Tao Wei,Shuguang Huang,Peining Chen,Ernst R. Dow,Avudaiappan Maran,Minzhi Zhang,Sutada Lotinun,Xi Lin,David L. Halladay,Rebecca R. Miles,Nalini H. Kulkarni,(unknown),Yanfei Li,Charles A. Frolik,Masahiko Sato,Henry U. Bryant,Russell T. Turner	75
6	Expression Profiling of Rat Femur Revealed Suppression of Bone Formation Genes by Treatment with Alendronate and Estrogen but Not Raloxifene 2005 ·Molecular Pharmacology ·Leah M. Helvering,(unknown),Nalini H. Kulkarni,Tao Wei,Peining Chen,Shuguang Huang,Frank Lawrence,David L. Halladay,Rebecca R. Miles,(unknown),Masahiko Sato,Yanfei Li,Charles A. Frolik,Ernst R. Dow,Henry U. Bryant,Jude E. Onyia	18
7	Novel and Selective Small Molecule Stimulators of Osteoprotegerin Expression Inhibit Bone Resorption 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Jude E. Onyia,Rachelle J. Sells Galvin,Yanfei Li,David L. Halladay,Rebecca R. Miles,Xuhao Yang,(unknown),(unknown),Qing Zeng,S. Chandrasekhar,Renee Emkey,Yanping Xu,Kannan Thirunavukkarasu,Henry U. Bryant,T. John Martin	27
8	Differential Effects of Estrogen and Raloxifene on Messenger RNA and Matrix Metalloproteinase 2 Activity in the Rat Uterus 2004 ·Biology of Reproduction ·Leah M. Helvering,Mary D. Adrian,Andrew G. Geiser,Shawn T. Estrem,Tao Wei,Shuguang Huang,P. Chen,Ernst R. Dow,John Calley,Jeffrey A. Dodge,Timothy A. Grese,(unknown),David L. Halladay,Rebecca R. Miles,J.E. Onyia,Yanfei Ma,Masahiko Sato,H.U. Bryant	29
9	Protein Kinase C Is a Mediator of the Synthesis and Secretion of Osteoprotegerin in Osteoblast-like Cells 2002 ·Biochemical and Biophysical Research Communications ·Xuhao Yang,David L. Halladay,Jude E. Onyia,T. John Martin,Srinivasan Chandrasekhar	8
10	Analysis of regulator of G‐protein signaling‐2 (RGS‐2) expression and function in osteoblastic cells 2002 ·Journal of Cellular Biochemistry ·Kannan Thirunavukkarasu,David L. Halladay,Rebecca R. Miles,(unknown),Jude E. Onyia	34
11	Parathyroid hormone (hPTH 1–38) stimulates the expression of UBP41, an ubiquitin‐specific protease, in bone 2002 ·Journal of Cellular Biochemistry ·Rebecca R. Miles,James P. Sluka,David L. Halladay,Robert F. Santerre,Laura V. Hale,Laura J. Bloem,(unknown),Rachelle J. Sells Galvin,Liandong Ma,Janet M. Hock,J.E. Onyia	17
12	Stimulation of Osteoprotegerin (OPG) Gene Expression by Transforming Growth Factor-β (TGF-β) 2001 ·Journal of Biological Chemistry ·Kannan Thirunavukkarasu,Rebecca R. Miles,David L. Halladay,Xuhao Yang,Rachelle J. Sells Galvin,S. Chandrasekhar,T. John Martin,Jude E. Onyia	117
13	Identification of signal transduction pathways and promoter sequences that mediate parathyroid hormone 1–38 inhibition of osteoprotegerin gene expression 2001 ·Journal of Cellular Biochemistry ·David L. Halladay,Rebecca R. Miles,Kannan Thirunavukkarasu,Srinivasan Chandrasekhar,T. John Martin,Jude E. Onyia	21
14	Catabolic Effects of Continuous Human PTH (1–38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation 2001 ·Endocrinology ·Yanfei Li,(unknown),David L. Halladay,Xuhao Yang,(unknown),Rebecca R. Miles,Srinivasan Chandrasekhar,T. John Martin,Jude E. Onyia	320
15	The Osteoblast-specific Transcription Factor Cbfa1 Contributes to the Expression of Osteoprotegerin, a Potent Inhibitor of Osteoclast Differentiation and Function 2000 ·Journal of Biological Chemistry ·Kannan Thirunavukkarasu,David L. Halladay,Rebecca R. Miles,Xuhao Yang,Rachelle J. Sells Galvin,S. Chandrasekhar,T. John Martin,Jude E. Onyia	151
16	The Human Transaldolase Gene (TALDO1) Is Located on Chromosome 11 at p15.4–p15.5 1997 ·Genomics ·Katalin Bánki,Roger L. Eddy,T.B. Shows,David L. Halladay,Florencia Bullrich,(unknown),Vesna Jurecic,Antonio Baldini,András Perl	13
17	Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. 1994 ·The Journal of Experimental Medicine ·Katalin Bánki,Emanuela Colombo,(unknown),David L. Halladay,David H. Mattson,Arthur H. Tatum,Paul T. Massa,Paul E. M. Phillips,András Perl	119
18	Cloning and expression of the human gene for transaldolase. A novel highly repetitive element constitutes an integral part of the coding sequence. 1994 ·Journal of Biological Chemistry ·Katalin Bánki,David L. Halladay,András Perl	68
19	The characterization of chromosome breaks in Drosophila melanogaster II. Molecular analaysis of γ-ray-induced deficiencies in the 14F–15A region 1986 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·(unknown),David L. Halladay	3
20	The characterization of chromosome breaks in Drosophila melanogaster 1984 ·Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis ·(unknown),(unknown),Sandra W. Curtiss,David L. Halladay,(unknown)	20

About David L. Halladay

David L. Halladay is a scholar working on Oncology, Immunology and Allergy and Molecular Biology, having authored 25 papers that have together received 1.7k indexed citations. Recurring topics across this work include Bone health and treatments (14 papers), Bone Metabolism and Diseases (14 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). The work is most often cited by research in Orthopedics and Sports Medicine (372 citations), Oncology (817 citations) and Nephrology (148 citations). David L. Halladay has collaborated with scholars based in United States and Australia. Frequent co-authors include Rebecca R. Miles, Jude E. Onyia, Xuhao Yang, T. John Martin, Rachelle J. Sells Galvin, Kannan Thirunavukkarasu, Yanfei Li, T. John Martin, S. Chandrasekhar and J.E. Onyia. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact